Cam Gallagher, President at Zentalis Pharmaceuticals, Inc. (ZNTL), sold 43,866 shares at $24.38 ($1.1M) on 2022-09-16, disclosed to the SEC on 2022-09-16.
Open-market sale of $1.1M ZNTL by President. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $25.10 | 8,426 | $211K | 19.4% |
| 2 | $25.10 | 8,426 | $211K | 19.4% |
| 3 | $25.59 | 4,074 | $104K | 9.5% |
| 4 | $25.59 | 4,074 | $104K | 9.5% |
| 5 | $24.38 | 8,866 | $216K | 19.8% |
| 6 | $24.38 | 8,866 |
| $216K |
| 19.8% |
| 7 | $24.99 | 1,134 | $28K | 2.6% |
| Total | $24.90 avg | 43,866 | $1.1M | 100% |
| Filing → |
| ZNTL | SELL | 2024-02-12 | $13K | — | Filing → |
| ZNTL | SELL | 2024-02-05 | $267K | — | Filing → |
| ZNTL | SELL | 2023-05-31 | $1.5M | — | Filing → |